Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia

Sin Man Lam1, Yuting Wang2, Xinrui Duan3

  • 1State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China; Department of Biological Sciences, National University of Singapore, Singapore.

Neurobiology of Aging
|April 2, 2014
PubMed

Insights

Subcortical ischemic vascular dementia (SIVD) mechanisms remain unclear. This study reveals altered lipid profiles in gray and white matter, suggesting new therapeutic targets for dementia.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Subcortical ischemic vascular dementia (SIVD) is the primary cause of vascular dementia.
  • Pathogenic mechanisms of SIVD are not fully understood, necessitating novel therapeutic targets.
  • Investigating lipidomic differences in SIVD and mixed dementia (MixD) may elucidate interactions between vascular and neurodegenerative processes.

Purpose of the Study:

  • To compare lipidomic profiles in the temporal cortex of nondemented controls, SIVD, and MixD subjects.
  • To identify potential molecular mechanisms and therapeutic targets in SIVD and MixD.

Main Methods:

  • Comparative lipidomic analysis using liquid chromatography coupled to mass spectrometry.
  • Analysis of white and gray matter from the temporal cortex.

Main Results:

  • Gray matter sphingolipid fatty acyl chain heterogeneity is pathologically relevant in dementia.
  • Progressive increases in sulfatides and lysobisphosphatidic acids were observed in gray matter from control to SIVD to MixD.
  • White matter phospholipid profiles suggest adaptive responses to ischemia in SIVD and membrane degradation in MixD.

Conclusions:

  • Lipidomic alterations, particularly in gray matter sphingolipids, are implicated in SIVD and MixD pathogenesis.
  • Specific lipid changes may serve as biomarkers or therapeutic targets for vascular dementia.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
687
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21